Pancreatic cancer has acquired another layer of biological complexity, according to a new study identifying a molecular pathway that may help tumors withstand gemcitabine, one of the most widely used chemotherapy drugs for the disease. Researchers led by H. Zhu, B. Xu, and R. Zhu report that vaccinia-related kinase 2, or VRK2, enables pancreatic cancer […]